Table 4 Baseline characteristics of the patients with liver fibrosis.
From: U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
Parameter | All patients |
|---|---|
Number | 64 |
Sex (male/female) | 40/24 |
Age median (range) (years) | 57 (29–82) |
Stage of cirrhosis, n (%) | |
No cirrhosis | 7 (10.9%) |
Child A | 24 (37.5%) |
Child B | 11 (17.2%) |
Child C | 22 (34.4%) |
Etiology, n (%) | |
Alcohol | 37 (57.8%) |
HBV | 2 (3.1%) |
HCV | 4 (6.3%) |
PBC | 19 (29.7%) |
PSC | 1 (1.6%) |
Other | 1 (1.6%) |
HCC (yes/no) | 53/11 |
MELD median (range) | 12 (6–28) |
Creatinine median (range) (mg dl−1) | 0.6 (0.0–1.7) |
Total bilirubin median (range) (mg dl−1) | 2.1 (0.2–43.2) |
IL-6 median (range) (pg ml−1) | 15 (2–200) |
AST median (range) (IU l−1) | 81 (11–294) |
ALT median (range) (IU l−1) | 43 (12–568) |
Quick median (range) (%) | 69 (33–100) |
Hyaluronan median (range) | 280 (10–800) |
